Prevalence and Risk Factors of Tamoxifen Retinopathy

Ophthalmology. 2020 Apr;127(4):555-557. doi: 10.1016/j.ophtha.2019.10.038. Epub 2019 Nov 7.

Authors

Hyun-Ah Kim¹, Suhwan Lee², Kyu Sang Eah¹, Young Hee Yoon³

Affiliations

¹ Department of Ophthalmology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
² Department of Ophthalmology, Kangwon National University Hospital, Kangwon National University Graduate School of Medicine, Chuncheon, Korea.
³ Department of Ophthalmology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. Electronic address: yhyoon@amc.seoul.kr.

PMID: 31813590
DOI: 10.1016/j.ophtha.2019.10.038

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Adult
Aged
Aged, 80 and over
Breast Neoplasms / drug therapy
Drug Prescriptions / statistics & numerical data
Female
Humans
Middle Aged
Photography / methods
Prevalence
Retina / drug effects*
Retinal Diseases / chemically induced*
Retinal Diseases / epidemiology*
Retrospective Studies
Risk Factors
Selective Estrogen Receptor Modulators / adverse effects*
Tamoxifen / adverse effects*
Tomography, Optical Coherence / methods
Young Adult

Substances

Selective Estrogen Receptor Modulators
Tamoxifen